Gilead Sciences at PepTalk 2027

Jan 18–21, 2027 Carlsbad, CA ~1k attendees Website

Gilead Sciences brings 6 presentations to PepTalk 2027 in Carlsbad. Its sessions focus on engineering and purifying multispecific antibodies and on predicting developability early. Specific work includes a T cell engager aimed at the PRAME peptide-MHC target in solid tumors and predicting ion-exchange binding to speed high-throughput purification.

OrganizationPepTalk 2027 Attendance
Gilead Sciences
Foster City, CA
Large pharma
Biopharmaceutical company with medicines for HIV, liver disease, cancer and inflammation, and research on antibodies and multispecifics.
Talk
Tue Jan 19
9:10am–9:40am
Chair
Tue Jan 19
1:25pm–1:30pm
Chairperson's Remarks
Multispecifics Engineering & Design
Talk
Wed Jan 20
5:10pm–5:40pm
Development of a PRAME pMHC Targeted T Cell Engager for Solid Tumor Therapy
Emerging T Cell Engagers
Chair
Thu Jan 21
8:35am–8:40am
Chairperson's Remarks
Tools for Purification and Quality
Talk
Thu Jan 21
8:40am–9:10am
Talk
Thu Jan 21
9:40am–10:10am

Explore the full PepTalk 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Carlsbad. Leave your work email and we’ll be in touch.

Privacy

Download the full PepTalk 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Gilead Sciences

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by PepTalk or its organizers. Submit a correction